Industry Intelligence
Corporate news from the pharmaceutical industry — M&A, earnings, executive appointments, restructuring and manufacturing investment.
Pharmaceutical consolidation is not a choice. It is a structural necessity imposed by the industry’s fundamental economics: massively expensive R&D that takes over a decade … Read more
When a biopharmaceutical company files an NDA (New Drug Application) with the FDA, the manufacturing site matters as much as the clinical data. A single … Read more
How a nearly $2 trillion market is reshaping itself around obesity drugs, where the growth is coming from, and why the industry’s earnings power is … Read more